The DOI matches its Crossref record; 208 of the 208 references it cites were found in a registry or an index.
Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy
Open accessAbstract
Hepatic encephalopathy (HE) is a frequent and serious complication of both chronic liver disease and acute liver failure. HE manifests as a wide spectrum of neuropsychiatric abnormalities, from subclinical changes (mild cognitive impairment) to marked disorientation, confusion and coma. The clinical and economic burden of HE is considerable, and it contributes greatly to impaired quality of life, morbidity and mortality. This review will critically discuss the latest classification of HE, as well as the pathogenesis and pathophysiological pathways underlying the neurological decline in patients with end-stage liver disease. In addition, management strategies, diagnostic approaches, currently available therapeutic options and novel treatment strategies are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–208 of 208
Ditisheim, S., Giostra, E., Burkhard, P. R., Goossens, N., Mentha, G., Hadengue, A., & Spahr, L. (2011) · BMC Gastroenterology · doi:10.1186/1471-230x-11-134 · Cited by 19
Neumann, T., Baum, A. K., Baum, U., Deike, R., Feistner, H., Scholz, M., Hinrichs, H., & Robra, B. (2019) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.08.012 · Cited by 19
Donor Age Predicts Calcineurin Inhibitor Induced Neurotoxicity After Liver Transplantation
Luè, A., Martinez, E., Navarro, M., Laredo, V., Lorente, S., Burdio, J. J. A., García‐Gil, F. A., & Serrano, T. (2019) · Transplantation · doi:10.1097/tp.0000000000002750 · Cited by 17
Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients
Cots, M. V., Carmona, I., Moreno, C., Ampuero, J., Simón‐Talero, M., Sanpedro, F., Les, Í., Romero‐Gómez, M., & Genescà, J. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17743419 · Cited by 15
Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs
Roggeri, A., Roggeri, D. P., Rossi, E., Cinconze, E., Gasbarrini, A., Preti, P. M., & Rosa, M. D. (2015) · Hepatic Medicine Evidence and Research · doi:10.2147/hmer.s87594 · Cited by 14
New technologies – new insights into the pathogenesis of hepatic encephalopathy
Baker, L. A., Lanz, B., Andreola, F., Ampuero, J., Wijeyesekera, A., Holmes, E. C., & Deutz, N. E. P. (2016) · Metabolic Brain Disease · doi:10.1007/s11011-016-9906-y · Cited by 12
Improvement of hyponatremia in cirrhosis is associated with improved complex information processing
Watson, H., Guevara, M., Vilstrup, H., & Ginés, P. (2019) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14683 · Cited by 11
Self-citationAgustí, A., Llansola, M., Hernández‐Rabaza, V., Cabrera‐Pastor, A., Montoliu, C., & Felipo, V. (2015) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2015.08.020 · Cited by 10
Cited by
Ginès, P., Krag, A., Abraldes, J. G., Solà, E., Fabrellas, N., & Kamath, P. S. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01374-x · Cited by 1,663
Cirrhosis-associated immune dysfunction
Albillos, A., Martin-Mateos, R., Van der Merwe, S., Wiest, R., Jalan, R., & Álvarez-Mon, M. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00520-7 · Cited by 447
Self-citationLiver diseases: epidemiology, causes, trends and predictions
Gan, C., Yuan, Y., Shen, H., Gao, J., Kong, X., Che, Z., Guo, Y., Wang, H., Dong, E., & Xiao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02072-z · Cited by 310
Pentón-Rol, G., Marín-Prida, J., & McCarty, M. F. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210408123807 · Cited by 73
Kronsten, V. T., & Shawcross, D. L. (2022) · Analytical Biochemistry · doi:10.1016/j.ab.2021.114437 · Cited by 27
Metadata
- Authors
- Rose, C. F., Amodio, P., Bajaj, J. S., Dhiman, R. K., Montagnese, S., Taylor-Robinson, S. D., Vilstrup, H., & Jalan, R.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2020-12
- Volume
- 73
- Issue
- 6
- Pages
- 1526-1547
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W3094334480
- Cited by
- 470
- References
- 208
- FWCI
- 25.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.